Position in PFE
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,161,786
-$218,093 QoQ
Shares Held
48,247
-1.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#1,236
of 2,821 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Onyx Bridge Wealth Group LLC holds $11,019,132 across 8 Drug Manufacturers - General names. PFE ranks #5 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
20,486 | $2,632,451 | |
| 2 | LLY |
ELI LILLY & Co
|
1,920 | $2,302,905 | |
| 3 | ABBV |
AbbVie Inc.
|
6,409 | $1,612,760 | |
| 4 | JNJ |
Johnson & Johnson
|
5,983 | $1,519,501 | |
| 5 | PFE |
Pfizer Inc
This page
|
48,247 | $1,161,786 | |
| 6 | AMGN |
Amgen Inc
|
1,929 | $698,529 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,931 | $622,981 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,126 | $468,219 |
All Filings in PFE
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,161,786 | 48,247 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $1,379,879 | 49,141 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $1,191,689 | 47,859 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $1,185,406 | 46,523 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $967,394 | 39,909 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $813,312 | 32,096 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $881,167 | 33,214 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $894,940 | 30,924 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $702,913 | 25,122 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $683,704 | 24,638 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $548,219 | 19,042 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $570,557 | 17,201 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $563,001 | 15,349 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $421,056 | 10,320 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $526,029 | 10,266 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $449,765 | 10,278 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $527,026 | 10,052 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $711,112 | 13,736 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $725,311 | 12,283 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $514,399 | 11,960 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $211,424 | 5,399 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $281,108 | 7,759 | Shares | Sole | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||